FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100846770> ?p ?o ?g. }

• W2100846770 endingPage "274" @default.
• W2100846770 startingPage "266" @default.
• W2100846770 abstract "Chronic systemic inflammation is common in patients with chronic kidney disease on dialysis (CKD5D) and has been considered a key mediator of the increased cardiovascular risk in this patient population. In this study, we tested the hypothesis that supplementation of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) will attenuate the systemic inflammatory process in CKD5D patients. The design was a randomized, double-blinded, placebo controlled pilot trial (NCT00655525). Thirty-eight patients were randomly assigned in a 1 : 1 fashion to receive 2.9 g of eicosapentaenoic acid (C20:5, n-3) plus docosahexaenoic acid (C22:6, n-3) versus placebo for 12 weeks. The primary outcome was change in pro-inflammatory chemokines measured by lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells (PBMCs). Secondary outcomes were changes in systemic inflammatory markers. Analysis of covariance was used to compare percent change from baseline to 12 weeks. Thirty-one patients completed 12 weeks and three patients completed 6 weeks of the study. Median age was 52 (interquartile range 45, 60) years, 74% were African-American and 79% were male. Supplementation of ω-3 PUFAs effectively decreased the LPS-induced PBMC expression of RANTES (Regulated upon Activation, Normal T cell Expressed and Secreted) and MCP-1 (Monocyte Chemotactic Protein-1; unadjusted P = 0.04 and 0.06; adjusted for demographics P = 0.02 and 0.05, respectively). There was no significant effect of the intervention on serum inflammatory markers (C-reactive protein, interleukin-6 and procalcitonin). The results of this pilot study suggest that supplementation of ω-3 PUFAs is beneficial in decreasing the levels of endothelial chemokines, RANTES and MCP-1. Studies of larger sample size and longer duration are required to further evaluate effects of ω-3 PUFAs on systemic markers of inflammation, other metabolic parameters and clinical outcomes, particularly cardiovascular outcomes in CKD5D patients." @default.
• W2100846770 created "2016-06-24" @default.
• W2100846770 creator A5028596742 @default.
• W2100846770 creator A5034692540 @default.
• W2100846770 creator A5036868114 @default.
• W2100846770 creator A5044924106 @default.
• W2100846770 creator A5050000155 @default.
• W2100846770 creator A5055104194 @default.
• W2100846770 creator A5057987348 @default.
• W2100846770 creator A5068118468 @default.
• W2100846770 creator A5082242825 @default.
• W2100846770 date "2014-09-09" @default.
• W2100846770 modified "2023-10-07" @default.
• W2100846770 title "Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients" @default.
• W2100846770 cites W1915928775 @default.
• W2100846770 cites W2008538480 @default.
• W2100846770 cites W2020730455 @default.
• W2100846770 cites W2032038343 @default.
• W2100846770 cites W2038523160 @default.
• W2100846770 cites W2066465207 @default.
• W2100846770 cites W2069044473 @default.
• W2100846770 cites W2074188218 @default.
• W2100846770 cites W2074702732 @default.
• W2100846770 cites W2078412057 @default.
• W2100846770 cites W2083285119 @default.
• W2100846770 cites W2089162544 @default.
• W2100846770 cites W2095967363 @default.
• W2100846770 cites W2096976658 @default.
• W2100846770 cites W2104516492 @default.
• W2100846770 cites W2104680689 @default.
• W2100846770 cites W2105206504 @default.
• W2100846770 cites W2107263703 @default.
• W2100846770 cites W2125469512 @default.
• W2100846770 cites W2127176760 @default.
• W2100846770 cites W2131133480 @default.
• W2100846770 cites W2131611586 @default.
• W2100846770 cites W2137858397 @default.
• W2100846770 cites W2140372161 @default.
• W2100846770 cites W2146571493 @default.
• W2100846770 cites W2156419944 @default.
• W2100846770 cites W4237475132 @default.
• W2100846770 cites W88281648 @default.
• W2100846770 doi "https://doi.org/10.1093/ndt/gfu283" @default.
• W2100846770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4309191" @default.
• W2100846770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25204316" @default.
• W2100846770 hasPublicationYear "2014" @default.
• W2100846770 type Work @default.
• W2100846770 sameAs 2100846770 @default.
• W2100846770 citedByCount "50" @default.
• W2100846770 countsByYear W21008467702015 @default.
• W2100846770 countsByYear W21008467702016 @default.
• W2100846770 countsByYear W21008467702017 @default.
• W2100846770 countsByYear W21008467702018 @default.
• W2100846770 countsByYear W21008467702019 @default.
• W2100846770 countsByYear W21008467702020 @default.
• W2100846770 countsByYear W21008467702021 @default.
• W2100846770 countsByYear W21008467702022 @default.
• W2100846770 countsByYear W21008467702023 @default.
• W2100846770 crossrefType "journal-article" @default.
• W2100846770 hasAuthorship W2100846770A5028596742 @default.
• W2100846770 hasAuthorship W2100846770A5034692540 @default.
• W2100846770 hasAuthorship W2100846770A5036868114 @default.
• W2100846770 hasAuthorship W2100846770A5044924106 @default.
• W2100846770 hasAuthorship W2100846770A5050000155 @default.
• W2100846770 hasAuthorship W2100846770A5055104194 @default.
• W2100846770 hasAuthorship W2100846770A5057987348 @default.
• W2100846770 hasAuthorship W2100846770A5068118468 @default.
• W2100846770 hasAuthorship W2100846770A5082242825 @default.
• W2100846770 hasBestOaLocation W21008467701 @default.
• W2100846770 hasConcept C119060515 @default.
• W2100846770 hasConcept C126322002 @default.
• W2100846770 hasConcept C137061746 @default.
• W2100846770 hasConcept C178790620 @default.
• W2100846770 hasConcept C185592680 @default.
• W2100846770 hasConcept C19038510 @default.
• W2100846770 hasConcept C202751555 @default.
• W2100846770 hasConcept C203014093 @default.
• W2100846770 hasConcept C2776091944 @default.
• W2100846770 hasConcept C2776252253 @default.
• W2100846770 hasConcept C2776914184 @default.
• W2100846770 hasConcept C2777171753 @default.
• W2100846770 hasConcept C2778063415 @default.
• W2100846770 hasConcept C2778653478 @default.
• W2100846770 hasConcept C2779978075 @default.
• W2100846770 hasConcept C2781195455 @default.
• W2100846770 hasConcept C2908647359 @default.
• W2100846770 hasConcept C543025807 @default.
• W2100846770 hasConcept C55493867 @default.
• W2100846770 hasConcept C71924100 @default.
• W2100846770 hasConcept C90924648 @default.
• W2100846770 hasConcept C99454951 @default.
• W2100846770 hasConceptScore W2100846770C119060515 @default.
• W2100846770 hasConceptScore W2100846770C126322002 @default.
• W2100846770 hasConceptScore W2100846770C137061746 @default.
• W2100846770 hasConceptScore W2100846770C178790620 @default.
• W2100846770 hasConceptScore W2100846770C185592680 @default.
• W2100846770 hasConceptScore W2100846770C19038510 @default.
• W2100846770 hasConceptScore W2100846770C202751555 @default.

• next